- Contact Information
5249 Femrite Drive
Madison, WI 53718
Ph: (608) 230-7160
Fax: (608) 230-7180
Mr. Messina has more than thirty years of managerial experience where in the past twenty (20) years has included the roles of Chief Operating Officer and since 1992 as a President and CEO. Mr. Messina has developed and executed strategic plans which included funding all of his business' M&A activity which involved identification, acquisition and assimilation those acquisitions. He also acquired and developed core technologies, involving complex license agreements, to establish a strong competitive technical advantage. He has raised equity, debt and mezzanine financing, restructured trade or bank debt to avoid bankruptcy, restructured company cost structure, identified and closed on strategic acquisitions, funding of those acquisitions, acquiring new technologies, developing world-wide distribution channels, and guided the sale of companies. In addition he has forged relationships with universities domestically and abroad in the continued development and commercialization of technologies developed in the university environment. His international experience also has included the founding of a joint venture in Shanghai, PRC, for the manufacture and distribution of medical device products throughout the Far East for Burdick. Mr. Messina received his BSEE in 1972 from New Jersey Institute of Technology and has completed study towards his MBA at Western New England College, Wilbraham, Massachusetts.
Mr. Isensee has over thirty years of design and managerial experience in the areas of scientific and medical instrumentation, including the role of Vice President of Technology for a major player in the medical device arena. During his career, responsibilities have included analog and digital design, project management, multi-discipline product design (industrial, electrical, mechanical, and software engineering), engineering research, manufacturing engineering, and quality assurance. His technology application areas have included scientific instrumentation, nuerology, cardiology and nuclear medicine. Mr. Isensee brings a unique management talent and understanding to the importance of "time to market" and "window of opportunity" and how risk management is a key to successful introduction of new technologies - all while meeting development costs and business cost-of-goods-sold goals. He has been responsible and managed efforts involving the Food and Drug Association, ISO-9000 and the European Union’s Medical Device Directive. His ability to strategically utilize technology expertise and managerial skill for a business advantage is a unique strength. Mr. Isensee received an A.S. degree in Biomedical Electronics in 1976 and a BSEE in 1980 from the University of Wisconsin - Madison.
Dr. Harvey has over thirty years of design and operational management experience in the area of scientific development and business operations. During his career, he either invented or was a co-inventor of several issued patented technologies. His operational responsibilities have included management of various laboratory operations in the nuclear and mixed waste operations support and environmental services. While involved in technology start-up companies, he was responsible for manufacturing, developed quality assurance programs for compliance to Nuclear Regulatory Commission and Department of Energy requirements, managed company activities to ensure compliance with federal and state regulations, and managed major government contracts involving federal research and development contracts. He has extensive experience in laboratory facility planning and build-out. Dr. Harvey received a B.S. degree in Chemistry in 1971 from the University of Virginia and a Ph.D. in Chemistry in 1977 from the University of Arkansas. He has also served as an officer in the USAF.
Mr. Moffatt has over twenty five years of experience in the quality assurance and regulatory affairs field, with the past sixteen years devoted to the manufacture of high tech medical devices and regualtory marketing submissions. Mr. Moffatt has extensive expertise with the regulations associated with medical device and drug product cGMP manufacturing, product/drug submissions and associated regulations. He has several years of experience with linear accelerators used for radiation therapy in the treatment of cancer. He was a leader for design and implementation of the manufacturing and quality system of a production facility in Chengdu, China. Mr. Moffatt’s first 10 years of his career was involved with the aerospace industry in which he gained experience with electronic counter measures for the protection of military aircraft. He has also applied the principals of lean six sigma improvement philosophies in the development of a corporate continuous improvement programs which have contributed to the company’s bottom line. Mr. Moffatt received a Bachelors of Science degree in Electrical Engineering from Iowa State University in 1983 and a Masters in Business Administration from Lewis University in 1989. He currently holds certifications of Quality Engineering from American Society of Quality (ASQ) and Lean Six Sigma from Wisconsin Manufacturing Extension Partnership (WMEP).
Dr. Horwitz is currently the Chief Scientific Officer of PG Research Foundation Inc. (PGRF), located in Darien, IL. He has spent his entire career in the scientific arena of chemical separation technologies, with many of these spent in the specialized area of radioisotopes. He worked for 38 years and retired the highest-ranking scientific officer at Argonne National Laboratory in Batavia, IL and is the holder of countless technology patents on the subject of chemical separations. Dr. Horwitz awards include the 1984 Glenn T. Seaborg Actinide Separations Award, the 2000 American Chemical Society Award in Separation Science and Technology, and in 2004, the prestigious Becquerel Medal Award presented by the Royal Society of Chemistry in London. As one of the inventors of the Licensed Technologies, Dr. Horwitz brings a level of expertise and enthusiasm not normally found with licensing technology. His technology intellect, worldwide recognition, and relationships with Eichrom Technologies offer an extraordinary technology advantage to NorthStar Medical Radioisotopes not available to its competition.